Newcleo Raises $247M in SPAC Deal, Advances Nuclear Reactor Development

  • Newcleo completed a SPAC merger on September 21, 2026, raising $247M in gross proceeds.
  • The company installed the main vessel and turbine for its PRECURSOR non-nuclear demonstration reactor, with completion expected by the end of 2026.
  • Newcleo was selected by the U.S. Department of Energy for advanced negotiations under the Surplus Plutonium Utilization Program.
  • The company received a satisfactory compliance opinion from the French Nuclear Safety and Radiation Protection Authority for its planned MOX fuel manufacturing facility.
  • Newcleo reported a 46% increase in revenue from products and services, reaching €19.4M for the first half of 2026.

Newcleo's SPAC merger and subsequent fundraising provide a significant financial boost to its advanced modular reactor development. The company's progress in regulatory engagements and technical validation positions it to play a meaningful role in the nuclear energy sector, particularly as global demand for clean and reliable energy sources grows. The strategic acquisitions and partnerships further strengthen its vertical integration and operational capabilities.

Regulatory Approvals
The pace at which newcleo secures regulatory approvals for its lead-cooled fast reactor and MOX fuel manufacturing facilities will determine its ability to deploy commercial reactors.
Technical Validation
The successful completion and validation of the PRECURSOR demonstration reactor will be critical for qualifying the technology for commercial deployment.
Financial Sustainability
Whether newcleo can sustain its high capital expenditures and manage its net loss while scaling its operations will be key to its long-term viability.